Member Info for Parpaing

according to Bloomberg see: http://www.bloomberg.com/quote/XBIO:US Now up 35% on the day ! My broker is showing the SP but not allowing any trades at the moment.

Now 1.15 - great!

According to my broker, our shares are not eligible to be traded yet. However, the broker is showing the SP on my portfolio. LordSnooty may know why we can't trade yet.

got it Cheers!

Roll on 27th March for more news.

Now quoted on Bloomberg http://www.bloomberg.com/quote/XBIO:US

Yes, got my allocation. tried to sell some just now but dealings are blocked with a comment"not negotiable at this time".Still showing the value as 9.5 USD per share. But check out LordSnooty's comment last week about the quote not being real and my broker being irresponsible to state the value on my trading account. so no change today. The shares are still in limbo. The only news for XEN is that Prof. Gregoriadis is retiring and Scott Maguire, CEO of Xenetic Biosciences said, "We are delighted to welcome Tim Cote to the board of Xenetic as his experience in heading the orphan drug division of the U.S. Food and Drug Administration (FDA) and deep knowledge on regulatory affairs in the U.S. and Europe, is a necessary addition to the skill set of the board as we move our products from research into the clinical phase of drug development. Tim's appointment is part of the planned changes reflecting the move to becoming a more clinically focused company with its key operations in the U.S. We now have a senior U.S. team with experience in the orphan drug market from both the industry and government perspectives, which will help us position our orphan drug candidates for regulatory approvals. Tim's appointment coupled with Baxter's $10 million investment and potential $100 million in cash milestones announced last week has provided an exciting start to our life in the U.S." See: http://ir.xeneticbio.com/releasedetail.cfm?ReleaseID=824378

My portfolio published on my broker's website clearly states the 8 USD value. So, as a test, I made a buy and sell. Neither went through as the shares are blocked, with the reason 'not negotiable'. So you must be right. Thank you for clearing this matter up for us. The bright side is seeing my portfolio 'green' instead of 'red' for the past two years. Thanks to you, I will not be disappointed when the SP 'plummets' next week !

You have 31,999 new shares in GAIFD (current value: 255,992USD as quoted on Bloomberg: http://www.bloomberg.com/quote/GAIFD:US).

I will check with my broker tomorrow. because my portfolio is being quoted as follows: 5.919 EUR giving a value of 5,919 EUR for every thousand shares I own. At current exchange rates this is eight dollars per share. I saw on Bloomberg that shares are being traded in GAIFD, so, maybe we are able to buy and sell now. At eight dollars per share, I could sell and get back in when they drop. Right now, 8 bucks is life changing for me.

Lots of press on XEN now, so your 15 USD might be reached much earlier than the Nasdaq listing as investors want a slice of the pie before the institutions get a look in.

Go to: http://www.bloomberg.com/ in the top right-hand search box, type xenetic. there will be two options. GAIFD and the Nasdaq sybol XEN1:PZ (pending listing). You will see that GAIFD is trading, reaching 10 USD and dropping to 9USD on a volume of 11,155. So, according to Bloonberg, the shares are being traded.

is now up 25 per cent to 10.00 on Bloomberg http://www.bloomberg.com/quote/GAIFD:US. XEN1:PZ is pending listing. hope it stays that way when we can trade.

Try this bank. http://www.britline.com/ I can confirm that their share dealing service is top notch and they have dealt with the XEN exchange process very professionally.

The price is realistic considering the hype in the US for XEn and the Baxter deal. XEN will be picked up very quickly. As to 'realistic' prices mentioned by Digger01, this term has no definition on stock markets. Otherwise, RBS would have a 'realistic' 0.001 pence GBP. It's all about being flavor of the month, marketing, bigging up the SP, chatter, greed, etc. Realistic pricing went out the door when computers and day trading came in.

LEXINGTON, Mass., Jan. 30, 2014 (GLOBE NEWSWIRE) -- Xenetic Biosciences, Inc. (OTCBB:GAIFD), a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics, today announced that it has received a direct investment of $10 million from Baxter International, Inc. and has agreed to a restructuring of certain financial and timing aspects of its existing licensing deal with Baxter. The amended license agreement includes increased contingent milestone payments, now totaling up to $100 million, as well as increased royalties on sales. http://www.globenewswire.com/news-release/2014/01/30/605931/10066187/en/Xenetic-Biosciences-Announces-Restructured-Licensing-Agreement-With-Baxter-Now-Totaling-Up-to-100-Million-in-Addition-to-10-Million-Equity-Investment.html

quoted on NASDAQ. http://www.nasdaq.com/symbol/gaifd.

8.00 USD today - a rise of 28 per cent -

http://www.bloomberg.com/quote/GAIFD:US

The line on my portfolio for: XENETIC BIOSCIENCES - US9840151073, 5.125 euros, performance 1,248,59% per cent. The colour of the amount is green, compared to my other shares (such as RBS) which are all in red and minus performance. So I'm in clover - until the share starts trading, according to mathsprof.